no icon
no icon
amc icon

Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct Plan Idcw Reinvestment

Equity | Sector Specific - Pharma

(NAV as of 19/04/2024)
22.61 (-0.31)

3Y Returns

8.22%

Min SIP

100

Min Lumpsum

5000

Expense Ratio

1.22%

Fund Size

2465 Cr

Inception Date

13-Jul-18

Fund Manager

Dharmesh Kakkad

Exit Load

1% on or before 15D, Nil after 15D.

Wealthzi View

Overall Fund Zi Tag

Asset Allocation

Equity

95.50%

Debt & Others

4.50%

Market Cap Allocation

Large Cap

41.66%

Mid Cap

27.66%

Small Cap

24.18%

Other Cap

6.50%

Sector Allocation

Pharmaceuticals

74.35%

Health Care

20.27%

Insurance

2.08%

Cash/Deposits/Margins/Treps/Repo/Swaps

1.52%

Chemicals

0.94%

Top Ten Holdings

Sun Pharmaceutical Industries Ltd

15.92%

Dr. Reddy'S Laboratories Ltd

8.76%

Cipla Ltd

7.05%

Lupin Ltd

6.33%

Apollo Hospitals Enterprises Ltd

6.17%

Investment Objective

To Generate Long-Term Capital Appreciation By Creating A Portfolio That Is Invested In Equity And Equity Related Securities Of Pharma, Healthcare, Hospitals, Diagnostics, Wellness And Allied Companies.However There Can Be No Assurance That The Investment Objectives Of The Scheme Will Be Realized.

Fund House Detail

AMC Name

ICICI Prudential Asset Management Company Limited

Address

One BKC, A - Wing 13th Floor,Bandra Kurla Complex, Bandra (East)Mumbai - 400 051

BUILD WEALTH WITH CONFIDENCE

no iconno iconno iconno icon
no icon

BSE Member code: 58371

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.
get on play storeget on app store

Wealthzi Investment Advisers (A division of Lime Internet Private Limited)

[CIN: U74999DL2017PTC310507] [PAN: AADCL2103M] [GSTIN: 07AADCL2103M1ZP]

[SEBI Registered Name: Lime Internet Private Limited] [SEBI RIA Registration No: INA000018133] [BASL Member ID: 2014] [Type of Registration: Non-Individual] [Validity of Registration: Perpetual] [Registered Address: Flat No. 603, 6th Floor, Kanchenjunga Building, 18 Barakhamba Road, New Delhi - 110001] [Principal Officer: Jyoti Prakash Nayak, Email: [email protected]] [Compliance Officer: Harshit Singh, Email: [email protected]] [Grievance Officer: Sahad PV, Email: [email protected]]

[SEBI Regional Office Address: Securities and Exchange Board of India, NBCC Complex, Office Tower-1, 8th Floor, Plate B, East Kidwai Nagar, New Delhi - 110023, Ph: 011-69012998, Email: [email protected]]

Disclaimers:

Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Registration granted by SEBI, membership of BASL and certification from National Institute of Securities Markets (NISM) in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The information is only for consumption by the client and such material should not be redistributed.